Maximal exercise test in patients with essential hypertension treated with propranolol

Area of Science:

• Cardiology
• Pharmacology
• Hypertension Research

Background:

• Essential hypertension poses significant cardiovascular risks.
• Exercise intolerance and ischemic changes are common in hypertensive patients.
• Left ventricular hypertrophy can complicate cardiac function in hypertension.

Purpose of the Study:

• To evaluate the effects of propranolol on exercise capacity and cardiac performance in hypertensive patients.
• To assess propranolol's impact on blood pressure, heart rate, and electrocardiographic ischemic changes during maximal exercise.
• To determine if propranolol improves exercise-induced cardiac stress markers in the presence of left ventricular hypertrophy.

Main Methods:

• A maximal exercise test was administered to 15 essential hypertension patients.
• Patients received oral propranolol (320 mg daily) for 10 days.
• Tests were conducted before and after the propranolol treatment period.

Main Results:

• Propranolol significantly reduced resting and post-exercise heart rate, systolic, and diastolic blood pressure.
• A trend towards greater workload tolerance was observed post-treatment.
• Significant reductions in heart rate-systolic blood pressure product and ischemic changes were noted.

Conclusions:

• Propranolol is an effective antihypertensive agent for essential hypertension.
• Propranolol improves exercise-induced ischemic changes and cardiac performance in hypertensive individuals.
• These benefits were observed even in patients with coexisting left ventricular hypertrophy.